{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in LRRK2 are a frequent cause of late-onset autosomal dominant PD. The G2019S mutation is the most common known genetic cause of PD and is associated with altered kinase activity.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Evaluate applicability of assays",
          "extracted_paper_info": "Binding and enzymatic assays were used to measure ATP affinity and kinase activity, which are directly relevant to LRRK2 function.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3: Evaluate validity of assays",
          "extracted_paper_info": "Wild-type LRRK2 was used as a control, and in vitro assays were performed with specific ATP concentrations. The data includes quantitative comparisons (e.g., 2-fold lower ATP affinity).",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "Wild-type LRRK2 was compared to the mutant variants, providing a direct control for ATP affinity and kinase activity measurements.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "G2019S exhibits 2-fold lower ATP affinity and higher kinase activity, which are key functional defects linked to PD pathogenesis."
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "The quantitative differences in ATP affinity and kinase activity (e.g., 2-fold, 1.6-fold) indicate significant functional disruption, supporting pathogenicity."
        }
      ],
      "strength_rating": "PS3_very_strong"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "2020"
        },
        "variant_string_id": "LRRK2 I2020T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "I2020T is associated with PD and affects ATP affinity and inhibitor resistance, which are critical for LRRK2 function.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Evaluate applicability of assays",
          "extracted_paper_info": "Binding and enzymatic assays were used to measure ATP affinity and inhibitor resistance, which are directly relevant to LRRK2 function.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3: Evaluate validity of assays",
          "extracted_paper_info": "Wild-type LRRK2 was used as a control, and in vitro assays were performed with specific ATP concentrations. The data includes quantitative comparisons (e.g., 6-fold higher ATP affinity).",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "Wild-type LRRK2 was compared to the mutant variants, providing a direct control for ATP affinity and kinase activity measurements.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "I2020T exhibits 6-fold higher ATP affinity and 10-fold resistance to inhibitors, which are key functional defects linked to PD pathogenesis."
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "The quantitative differences in ATP affinity and inhibitor resistance (e.g., 6-fold, 10-fold) indicate significant functional disruption, supporting pathogenicity."
        }
      ],
      "strength_rating": "PS3_very_strong"
    }
  ]
}